688621.SH
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 54.36
+1.99%Oct 29, 2026, 08:06 UTC
Sunshine Guojian reported third-quarter 2026 revenue of 219 million yuan, down 17.46% year over year, and a net loss attributable to shareholders of 10.1413 million yuan, down 130.31%; for the first nine months of 2026, revenue was 645 million yuan, down 24.60%, and the attributable net loss was 34.5413 million yuan, down 121.15%.
Source:Sep 28, 2026, 09:56 UTC
Sunshine Nuohe announced that its wholly owned subsidiary Nuohe Shengtai's STC008 injection met the expected goals in a Phase I clinical trial for treating cancer cachexia in advanced solid tumors.
Source:Sep 24, 2026, 07:48 UTC
Sunshine Nuohe and Hunan Hengsheng Pharmaceutical reached a court-mediated settlement of multiple lawsuits, with all contracts terminated and no outstanding debts between them.
Source:Sep 16, 2026, 09:30 UTC
Sunshine Lake Pharma's BTP0427 compound sustained-release capsules (Specifications I and II) received clinical trial approval from China's National Medical Products Administration for treating chronic heart failure with reduced ejection fraction.